These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 36506508)

  • 1. Exploration of the effect of Celastrol on protein targets in nasopharyngeal carcinoma: Network pharmacology, molecular docking and experimental evaluations.
    Ling J; Huang Y; Sun Z; Guo X; Chang A; Pan J; Zhuo X
    Front Pharmacol; 2022; 13():996728. PubMed ID: 36506508
    [No Abstract]   [Full Text] [Related]  

  • 2. The mechanisms of celastrol in treating papillary thyroid carcinoma based on network pharmacology and experiment verification.
    Yi J; Tian M; Hu L; Kang N; Ma W; Zhi J; Zheng X; Ruan X; Gao M
    Ann Transl Med; 2021 May; 9(10):866. PubMed ID: 34164500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Network Pharmacology and Experimental Validation to Explore That Celastrol Targeting PTEN is the Potential Mechanism of
    Zhao J; Liu H; Xia M; Chen Q; Wan L; Leng B; Tang C; Chen G; Liu Y; Zhang L; Liu H
    Drug Des Devel Ther; 2023; 17():887-900. PubMed ID: 36992900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
    Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
    J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Network pharmacology and experimental verification-based strategy for exploring the mechanisms of luteolin in the treatment of osteosarcoma.
    Huang R; Xu M; Guo W; Cheng M; Dong R; Tu J; Xu S; Zou C
    Cancer Cell Int; 2023 Sep; 23(1):213. PubMed ID: 37749554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Luteolin Isolated from
    Xiong Y; Zhong W; Liu J; Cheng B; Fan J; Zhou F; He L; Tian D; He Y
    Biomed Res Int; 2022; 2022():9740066. PubMed ID: 36588531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xiao-Luo-Wan treats propylthiouracil-induced goiter with hypothyroidism in rats through the PI3K-AKT/RAS pathways based on UPLC/MS and network pharmacology.
    Dong S; Liu Q; Jiang M; Ma Q; Huang Q; Liu T; Li Y; Ni L; Shi Y
    J Ethnopharmacol; 2022 May; 289():115045. PubMed ID: 35101570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidating the pharmacological effects of Compound Kushen injection on MYC-P15-CCND1 signaling pathway in nasopharyngeal carcinoma - An in vitro study.
    Wu Z; Wu C; Shi J; Huang Z; Lu S; Tan Y; You R; Hai L; Huang J; Guo S; Gao Y; Jin Z; Tao X; You L; Wu J
    J Ethnopharmacol; 2023 Oct; 315():116702. PubMed ID: 37257705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deciphering the pharmacological mechanisms of Scutellaria baicalensis Georgi on oral leukoplakia by combining network pharmacology, molecular docking and experimental evaluations.
    Hou F; Yu Z; Cheng Y; Liu Y; Liang S; Zhang F
    Phytomedicine; 2022 Aug; 103():154195. PubMed ID: 35667260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of
    Lu L; Peng J; Wan P; Peng H; Lu J; Xiong G
    Front Pharmacol; 2022; 13():940773. PubMed ID: 36386135
    [No Abstract]   [Full Text] [Related]  

  • 11. Frankincense myrrh attenuates hepatocellular carcinoma by regulating tumor blood vessel development through multiple epidermal growth factor receptor-mediated signaling pathways.
    Zheng P; Huang Z; Tong DC; Zhou Q; Tian S; Chen BW; Ning DM; Guo YM; Zhu WH; Long Y; Xiao W; Deng Z; Lei YC; Tian XF
    World J Gastrointest Oncol; 2022 Feb; 14(2):450-477. PubMed ID: 35317323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining bioinformatics, network pharmacology and artificial intelligence to predict the mechanism of celastrol in the treatment of type 2 diabetes.
    Wu M; Zhang Y
    Front Endocrinol (Lausanne); 2022; 13():1030278. PubMed ID: 36339449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
    Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
    Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploration of the Effect and Potential Mechanism of Echinacoside Against Endometrial Cancer Based on Network Pharmacology and in vitro Experimental Verification.
    Shu W; Wang Z; Zhao R; Shi R; Zhang J; Zhang W; Wang H
    Drug Des Devel Ther; 2022; 16():1847-1863. PubMed ID: 35734366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying the Effect of Celastrol Against Ovarian Cancer With Network Pharmacology and
    Wang X; Liu Q; Wu S; Xu N; Li H; Feng A
    Front Pharmacol; 2022; 13():739478. PubMed ID: 35370699
    [No Abstract]   [Full Text] [Related]  

  • 16. In silico analysis and experimental validation to exhibit anti-nasopharyngeal carcinoma effects of plumbagin, an anti-cancer compound.
    Liang X; Pan Q; Liao Y; Nie L; Yang L; Liu F; Su M
    J Sci Food Agric; 2022 Sep; 102(12):5460-5467. PubMed ID: 35355274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
    Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
    Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Assessment of
    Shi H; Liu J; Fan J; He L; Wang X; Tang F; Tian D; He Y
    Evid Based Complement Alternat Med; 2022; 2022():1988378. PubMed ID: 35178099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative transcriptomics and network pharmacology analysis to identify the potential mechanism of celastrol against osteoarthritis.
    Dai S; Wang H; Wang M; Zhang Y; Zhang Z; Lin Z
    Clin Rheumatol; 2021 Oct; 40(10):4259-4268. PubMed ID: 33870466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connective tissue disease-related interstitial lung disease is alleviated by tripterine through inhibition of the PI3K/Akt, apoptosis, and TNF-α signalling pathways.
    Zhu W; Wang Y; Liu C; Wu Y; Li Y; Wang Y
    Front Pharmacol; 2022; 13():990760. PubMed ID: 36419618
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.